ORTHOPEDIATRICS CORP (KIDS) Nonoperating Income (Expense) USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Orthopediatrics Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2024.
  • Orthopediatrics Corp Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$613 K, a 151% decline year-over-year.
  • Orthopediatrics Corp Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $3.62 M, a 86.1% decline year-over-year.
  • Orthopediatrics Corp annual Nonoperating Income (Expense) for 2023 was $5.44 M, a 74.9% decline from 2022.
  • Orthopediatrics Corp annual Nonoperating Income (Expense) for 2022 was $21.7 M, a 3314% increase from 2021.
  • Orthopediatrics Corp annual Nonoperating Income (Expense) for 2021 was $636 K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.62 M -$613 K -$1.82 M -151% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.44 M $1.16 M +$750 K +182% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $4.69 M $766 K -$20.6 M -96.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $25.3 M $2.3 M -$672 K -22.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $26 M $1.21 M +$4.24 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $21.7 M $413 K -$4.98 M -92.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $26.7 M $21.4 M +$20.2 M +1749% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $6.49 M $2.97 M +$4.17 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $2.32 M -$3.03 M +$1.69 M +35.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $636 K $5.4 M +$7.39 M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-08
Q3 2021 -$6.75 M $1.16 M +$3.2 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$9.95 M -$1.2 M +$1.23 M +50.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$11.2 M -$4.72 M -$4.27 M -953% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$6.91 M -$1.99 M -$695 K -53.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$6.22 M -$2.04 M -$703 K -52.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$5.51 M -$2.43 M -$1.76 M -263% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$3.75 M -$448 K -$145 K -47.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$3.61 M -$1.3 M -$696 K -116% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 -$2.91 M -$1.34 M -$645 K -93.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$2.27 M -$669 K -$97 K -17% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$2.17 M -$303 K +$302 K +49.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$2.47 M -$602 K +$1.22 M +66.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-11
Q3 2018 -$3.69 M -$693 K +$88 K +11.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$3.78 M -$572 K -$1.16 M -197% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$2.62 M -$605 K -$157 K -35% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$2.46 M -$1.82 M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 -$781 K -$459 K -143% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $589 K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$448 K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 -$322 K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.